State Ledger
Company profile

ELI LILLY & Co CIK 59478

Ticker
LLY (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Indianapolis, IN 46285
Fiscal year end
2025 (FY)
Market Data
Close
$1,178.19
Change
+$8.58
Change %
0.73%
Volume
59,451

LLY · trading date Oct 9, 2026 · previous close $1,169.61 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$65.18B
Net income
$20.64B
Total assets
$112.48B
Total liabilities
—
Stockholders' equity
$26.54B
Cash & equivalents
$7.27B
Operating income
—
Operating cash flow
$16.81B
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-02-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
31.7%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
23.6%
CapEx / revenue
—
Operating cash flow / net income
0.81×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $65.18B $20.64B $112.48B — $26.54B
2024 $45.04B $10.59B $78.72B — $14.27B
2023 $34.12B $5.24B $64.01B — $10.77B
2022 $28.54B $6.24B $49.49B — $10.65B
2021 $28.32B $5.58B $48.81B — $8.98B
Company Details
SIC code
2834
State of incorporation
IN
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-11
Financials filed via
Form 10-K
filed 2026-02-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Indianapolis, IN 46285
LILLY CORPORATE CTR
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:30 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Indiana — Public Companies